3rd Quarter - Report

VALNEVA USA, INC. for VALNEVA USA, INC.

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the State Stockpile Grant program; Issues related to Strategic National Stockpile procurement regarding new emerging infection diseases and in relation to the Preparedness Act (PAHPA) reauthorization; Issues related to the FDA's Priority Review Voucher; Issues related to reauthorization of the publican health emergency medical countermeasures enterprise; Enhancing immunization access for military dependents

Foreign entity interest: Foreign entities identified on form LD-1 have an interest in the lobbying issues.

LobbyistCovered position, as disclosed
AMANDA ARNOLD —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.